Related Experiment Video

Updated: May 24, 2026

Isolation of Endothelial Progenitor Cells from Healthy Volunteers and Their Migratory Potential Influenced by Serum Samples After Cardiac Surgery
08:43

Isolation of Endothelial Progenitor Cells from Healthy Volunteers and Their Migratory Potential Influenced by Serum Samples After Cardiac Surgery

Published on: February 14, 2017

Endothelial progenitor cells: a new player in lupus?

Sahena Haque1, M Yvonne Alexander, Ian N Bruce

  • 1Arthritis Research UK Epidemiology Unit, School of Translational Medicine, Manchester Academic Health Science Centre, The University of Manchester, Oxford Road, Manchester, M13 9PT, UK.

Arthritis Research & Therapy
|February 24, 2012
PubMed

Insights

Systemic lupus erythematosus (SLE) patients face higher cardiovascular disease risks due to impaired endothelial repair. Endothelial progenitor cells may contribute to vascular damage and offer a potential therapeutic target in SLE.

Area of Science:

  • Cardiovascular research
  • Rheumatology
  • Vascular biology

Background:

  • Systemic lupus erythematosus (SLE) significantly elevates cardiovascular disease (CVD) risk.
  • Inflammatory factors specific to lupus are increasingly linked to vascular damage.
  • Endothelial dysfunction in SLE patients may stem from impaired endothelial repair mechanisms.

Purpose of the Study:

  • To review the role of endothelial progenitor cells (EPCs) in the pathogenesis of premature vascular damage in SLE.
  • To discuss EPCs as a potential therapeutic target for vascular complications in SLE.

Main Methods:

  • Review of literature on EPC isolation, detection, and characterization.
  • Analysis of EPCs' function in endothelial repair.
  • Exploration of therapeutic strategies targeting EPCs in SLE.

Main Results:

  • EPCs are crucial for endothelial repair.
  • Dysfunctional EPCs may contribute to accelerated atherosclerosis in SLE.
  • EPCs represent a promising therapeutic avenue for SLE-related vascular disease.

Conclusions:

  • EPC dysfunction is implicated in the pathogenesis of vascular damage in SLE.
  • Targeting EPCs holds potential for treating cardiovascular complications in SLE patients.

More Related Videos

Isolation of Endothelial Progenitor Cells from Human Umbilical Cord Blood07:26

Isolation of Endothelial Progenitor Cells from Human Umbilical Cord Blood

Published on: September 14, 2017

Phenotypic and Functional Characterization of Endothelial Colony Forming Cells Derived from Human Umbilical Cord Blood13:46

Phenotypic and Functional Characterization of Endothelial Colony Forming Cells Derived from Human Umbilical Cord Blood

Published on: April 13, 2012

Related Concept Videos

Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
Production of Formed Elements01:34

Production of Formed Elements

Hemangioblasts are multipotent stem cells originating from the mesoderm. They give rise to hematopoietic stem cells (HSCs), which undergo hematopoiesis to produce all the formed elements of blood. This process is regulated by a complex network of hematopoietic growth factors, including transcription factors, growth factors, and cytokines. These factors stimulate the HSCs to divide and differentiate, though some HSCs remain undifferentiated to maintain a self-renewing pool.
Most HSCs commit to...
Multipotency of Hematopoietic Stem Cells01:19

Multipotency of Hematopoietic Stem Cells

The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
Lineage Commitment01:21

Lineage Commitment

Commitment is the  process whereby stem cells:
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
Hematopoiesis01:21

Hematopoiesis

The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...